Literature DB >> 10651605

The diastolic blood pressure in systolic hypertension.

H Smulyan1, M E Safar.   

Abstract

Because antihypertensive therapy is effective in elderly patients with isolated systolic hypertension, attention has been focused on the systolic blood pressure as a predictor of cardiovascular risk. However, it is a normal diastolic pressure that separates patients with isolated systolic hypertension from those with essential hypertension. The normal diastolic and elevated systolic pressures are largely due to age-related stiffening of the aorta. An indistensible aorta causes the pressure pulse to travel faster than normal, where it is quickly reflected off the peripheral resistance. The reflected wave then returns to the central aorta in systole rather than diastole. This augments the systolic pressure further, increasing cardiac work while reducing the diastolic pressure, on which coronary flow is dependent. The potential harm of further reducing the diastolic pressure with antihypertensive therapy, especially in patients with coronary heart disease, underlies the controversial "J curve." By decreasing the blood pressure, all antihypertensive agents improve aortic distensibility, but no agents do so directly; the nitrates come the closest. Such an agent would be useful because any therapeutic increase in aortic distensibility would decrease systolic pressure without greatly reducing diastolic pressure. The problem is complicated by the suspected inaccuracy of the cuff technique in predicting the aortic diastolic pressure. New noninvasive methods to predict the aortic diastolic pressure may help in the future. At present, the combination of a high systolic and normal diastolic pressure-a widened pulse pressure-seems to be the best predictor of cardiovascular risk in patients with hypertension or heart disease. Patients with isolated systolic hypertension should be treated, but marked diastolic hypotension should be avoided.

Entities:  

Mesh:

Year:  2000        PMID: 10651605     DOI: 10.7326/0003-4819-132-3-200002010-00010

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

Review 1.  Endothelin and the "seventh inning stretch".

Authors:  F C Luft
Journal:  J Mol Med (Berl)       Date:  2000       Impact factor: 4.599

Review 2.  Systolic versus diastolic blood pressure versus pulse pressure.

Authors:  William B White
Journal:  Curr Cardiol Rep       Date:  2002-11       Impact factor: 2.931

Review 3.  Are there benefits of antihypertensive therapy beyond blood pressure lowering?

Authors:  Joseph L Izzo
Journal:  Curr Hypertens Rep       Date:  2010-12       Impact factor: 5.369

4.  Blood pressure variability and white matter hyperintensities in older adults with cardiovascular disease.

Authors:  John Gunstad; Ronald A Cohen; David F Tate; Robert H Paul; Athena Poppas; Karin Hoth; Kristin L Macgregor; Angela L Jefferson
Journal:  Blood Press       Date:  2005       Impact factor: 2.835

Review 5.  Unsolved Problem: (Isolated) Systolic Hypertension with Diastolic Blood Pressure below the Safety Margin.

Authors:  Goran Koracevic; Milovan Stojanovic; Tomislav Kostic; Dragan Lovic; Miloje Tomasevic; Ruzica Jankovic-Tomasevic
Journal:  Med Princ Pract       Date:  2020-05-07       Impact factor: 1.927

6.  Progression is accelerated from prehypertension to hypertension in blacks.

Authors:  Anbesaw Selassie; C Shaun Wagner; Marilyn L Laken; M LaFrance Ferguson; Keith C Ferdinand; Brent M Egan
Journal:  Hypertension       Date:  2011-09-12       Impact factor: 10.190

7.  Isolated systolic hypertension and incident heart failure in older adults: a propensity-matched study.

Authors:  O James Ekundayo; Richard M Allman; Paul W Sanders; Inmaculada Aban; Thomas E Love; Donna Arnett; Ali Ahmed
Journal:  Hypertension       Date:  2009-02-02       Impact factor: 10.190

8.  Cardiovascular impact of exercise and drug therapy in older hypertensives with coronary heart disease: PREHACOR study.

Authors:  Jean-Jacques Mourad; Nicolas Danchin; Jacques Puel; Hervé Gallois; Jérôme Msihid; Michel E Safar; Hirofumi Tanaka
Journal:  Heart Vessels       Date:  2008-02-14       Impact factor: 2.037

9.  Quantifying risk of adverse clinical events with one set of vital signs among primary care patients with hypertension.

Authors:  William M Tierney; Margaret Brunt; Joseph Kesterson; Xiao-Hua Zhou; Gil L'Italien; Pablo Lapuerta
Journal:  Ann Fam Med       Date:  2004 May-Jun       Impact factor: 5.166

10.  Mid-regional pro-adrenomedullin is associated with pulse pressure, left ventricular mass, and albuminuria in African Americans with hypertension.

Authors:  Malik A Al-Omari; Mahyar Khaleghi; Thomas H Mosley; Stephen T Turner; Nils G Morgenthaler; Joachim Struck; Andreas Bergmann; Iftikhar J Kullo
Journal:  Am J Hypertens       Date:  2009-05-07       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.